The updated boosters from Pfizer-BioNTech and Moderna are probably best reserved for people at high risk of severe illness or death from Covid
boosters
Dr. Paul Offit reiterated his opposition to the bivalent booster in a Sept 21 op-ed for the Wall Street Journal
The lack of human data means officials likely won’t know how much better the new shots are — if at all — until the fall booster campaign is well underway
The data available is not sufficient
As of Friday, over 2.5 million Israelis had received the third dose
Rocket recycling is the name of the game
They will help form one of the two, five-segment motors to be mounted to the Artemis 1 SLS core stage
Life is better than Hollywood...